In our study, serum VEGF-D levels were elevated in patients with lymphangioleiomyomas as previously reported [8, 11], but not in those with other lymphatic manifestations, such as chylous effusions (Table 2). This evidence concerns the gene VEGFD and lymphangiomyoma.